Title: A Study of the Adverse Drug Effect Profile of Phenytoin in A Tertiary Hospital in North East India

Authors: Indrani Bhagawati, Bhaskarjyoti Thakuria

 DOI:  https://dx.doi.org/10.18535/jmscr/v5i6.145

Abstract

Introduction: Epilepsy is a chronic neurological disorder characterized by recurrent seizures of cerebral origin which have been known to inflict mankind since ancient times. The seizure nearly always correlates with an abnormal EEG discharge. Epilepsy continues to be one of the commonest disorders seen in neurology clinics all over the world. Hence the antiepileptic drugs are the most abundantly prescribed drugs by the neurologist and phenytoin being the most effective, it is widely prescribed as first line drugs in spite of many newer antiepileptics. Unfortunately phenytoin has a wide spectrum of adverse effects ranging from being reversible effect to severe life threatening conditions. Objective: The objective of the current study is to analyze and evaluate the adverse effects of phenytoin in the Neurology department in a tertiary care teaching hospital in North East India.

Methodology: This study was a prospective observational study on patients in the neurology department. A random once weekly data collection was done for a period of 1 year. Patients of all ages and both sexes were included in the study. Informed consent was obtained verbally from the patient’s legal guardian. Every patient was examined clinically and their side effects were detected. Patient related information and drug related information (like dose, dosage form, route of administration) was recorded on a data collection sheet. The data obtained was analysed and presented with appropriate statistical methods.

Results: Most common adverse effects of phenytoin observed in the study were gum hyperplasia (24%), dermatological changes comprising skin pigmentation, coarsening of facial features and hirsutism, CNS related ataxia, nystagmus and cerebellar involvement (20%).

Keywords: epilepsy, phenytoin, adverse drug effects, prospective study, gum hyperplasia.

References

1.      Sridharan R (2002) Epidemiology of epilepsy.     Current Science 82: 664-670.

2.      Cloyd JC, Remmel RP. Antiepielptic drug pharmacokinetics and interactions: impact on treatment of epilepsy. Pharmacotherapy 2000; 20 Pt 2 (8): 139S-151S.

3.      Foletti GB. Clinical utilization of newer anti-epileptic agents. Rev Med Suisse Romande 2000 Sep; 120(9): 703-7.

4.      Schlienger RG, Shear NH. Antiepileptic drug hypersensitivity syndrome. (Review), Epilepsia 1998, 39 SUPPL. 7: 93-97.

5.      Hamer HM, Morris HH. Hypersensitivity syndrome to antiepileptic drugs- a review including new anticonvulsants. Cleveland Clinic Journal of Medicine, 66(4), 239-245, 1999 April.

6.      Knott C, Williams CP, Reynolds F. Phenytoin kinetics during pregnancy and the puerperium. BJOG: An International Journal of Obstetrics & Gynaecology 1986, 93: 1030–1037.

7. Richens, A., Dunlop, A. Serum phenytoin levels in management of epilepsy. Lancet 1975, ii, 247-248.

Corresponding Author

Bhaskarjyoti Thakuria

Department of Pharmacology

Fakhruddin Ali Ahmed Medical College & Hospital, Barpeta, Assam, India

Email: This email address is being protected from spambots. You need JavaScript enabled to view it.